ARCHIVES

In Brief: No Intention Of Cutting Back On Cancer, Heart Research, Weinberger Spokesman Insists

This article is from The Cancer Letter archive.

Vol. 01 No. 18 | June 7, 1974

Download PDF Visit The Full Archive

Related Articles

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

House Subcommittee To Hold Hearings On Cancer Program

June 10, 1977

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995